clinical trial · NCT07028281
A Trial of SHR-4849 Combined With Other Antitumor Drugs in Patients With Malignant Solid Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd.·phase2·recruiting·n = 120
Malignant Solid TumorsSHR-4849、SHR-1316、SHR-8068、BP102、carboplatin、cisplatin
brief summary
The study is being conducted to evaluate the safety, tolerability and efficacy of SHR-4849 injection combined with other antitumor drugs in patients with malignant solid tumors.
started
Jul 8, 2025
primary completion
Dec 1, 2028
completion
Dec 1, 2028
last updated
Mar 3, 2026
official title
A Multicenter, Open-label, Phase II Clinical Study of SHR-4849 Injection Combined With Other Antineoplastic Drugs in Patients With Malignant Solid Tumors
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol